Moderna Inc. Chief Medical Officer Paul Burton has announced that they are working rapidly to test the current vaccine against the Omicron variant and studying two booster candidates. 

Current data suggests that protection against the new strain still exists, depending on the length of time passed from an individual’s second vaccine dose. 

To read the full article, please follow the link below:

Moderna says new vaccine for Omicron variant may be ready in early 2022